BOWIE, Md., March 07, 2016 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based analytics and data-driven intervention platforms to the healthcare industry, today announced that its 2016 annual meeting of stockholders will be held on Wednesday, May 18, 2016, at 10 a.m. EDT at the Westin Annapolis Hotel located at 100 Westgate Circle, Annapolis, Maryland 21401.
The record date for determining those stockholders entitled to vote at the 2016 annual meeting of stockholders is the close of business on March 24, 2016. The close of business on Thursday, March 17, 2016 is the deadline for stockholders to submit director nominations or stockholder proposals for presentation before the 2016 annual meeting of stockholders. Any Inovalon stockholder who wishes to submit a director nomination or stockholder proposal must deliver the information required by Inovalon’s bylaws in writing no later than Thursday, March 17, 2016 to the attention of Inovalon’s Corporate Secretary, 4321 Collington Road, Bowie, Maryland 20716.
Inovalon is a leading technology company that combines advanced, cloud-based data analytics, and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Inovalon's unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, data-driven intervention platforms, and deep subject matter expertise deliver a seamless, end-to-end capability that brings the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance – while bringing to bear the unique capabilities to resolve them. Providing technology that supports hundreds of healthcare organizations in 98.2% of U.S. counties and Puerto Rico, Inovalon's cloud-based analytical and data-driven intervention platforms are informed by data pertaining to more than 784,000 physicians, 269,000 clinical facilities, and more than 130 million Americans. Through these capabilities, and those of its subsidiary Avalere Health, Inc., which offers data-driven advisory services and business intelligence to more than 200 pharmaceutical and life sciences enterprises, Inovalon is able to drive high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers. For more information, visit www.inovalon.com.
Contacts: Inovalon Kim E. Collins Phone: 301-809-4000 x1473 email@example.com
Source:Inovalon Holdings, Inc.